前列腺癌治疗中定期成像监测分次内运动的前瞻性双替代验证研究
共采集4054张治疗中图像,两种方法向量幅度差异均值0.03 cm(SD 0.16 cm),Lin一致性相关系数0.99(95%CI 0.98,1)。结论认为该算法检测2D图像中标记的准确性与电磁监测相当,可作为电磁监测禁忌患者的替代方案。
要点
- 定期成像的标记检测算法与电磁监测在前列腺癌分次内运动监测中准确性相当。
- 两种方法向量幅度差异均值0.03 cm(SD 0.16 cm),Lin一致性相关系数0.99。
- 该方案不能提供治疗前摆位验证和治疗中实时3D定位数据。
核心结论
- 定期成像中标记检测算法检测2D图像内标记的准确性与电磁监测对基准标记识别相当。
- 该方法可作为电磁监测系统禁忌患者的替代方案,并作为避免额外采购监测系统的成本效益选择。
- 该方法不提供治疗前摆位验证和治疗中实时3D定位数据。
研究设计与样本
- 比较定期成像中基准标记检测算法报告的位置数据与电磁监测系统已知信标位置。
主要发现
- 治疗期间共采集4054张图像。
- 两种方法向量幅度差异以零为中心(均值0.03 cm,SD 0.16 cm),Lin一致性相关系数总体为0.99(95%CI 0.98,1)。
- 两种方法间欧氏距离接近零(中位数0.09 cm,IQR 0.06,0.14 cm)。
- 任意两标记间距离差异以零为中心(均值0.01 cm,SD 0.12 cm),Lin一致性相关系数总体为0.97(95%CI 0.96,0.98)。
关键数值与推荐
- 向量幅度差异均值0.03 cm(SD 0.16 cm),Lin一致性相关系数0.99(95%CI 0.98,1)。
- 欧氏距离中位数0.09 cm(IQR 0.06,0.14 cm)。
- 任意两标记间距离差异均值0.01 cm(SD 0.12 cm),Lin一致性相关系数0.97(95%CI 0.96,0.98)。
临床怎么用
- 对于电磁监测系统禁忌的前列腺癌放疗患者,可考虑定期成像标记检测算法作为分次内运动监测的替代方案。
- 该方法不能替代治疗前摆位验证和治疗中实时3D定位,临床决策需明确其适用范围。
局限性
- 该方法不提供治疗前摆位验证和治疗中实时3D定位数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: The goal of this prospective study is to validate the use of periodic imaging during treatment with a fiducial marker detection algorithm using radiofrequency transponders for prostate cancer patients undergoing treatment for radiation therapy. MATERIALS AND METHODS: Ten male patients were enrolled in this study and treated for prostate cancer with implanted electromagnetic monitoring beacons. We evaluated the accuracy and limitations of Intrafraction Motion Review (IMR) by comparing the known locations of the beacons using the electromagnetic monitoring system to the position data reported from IMR images. RESULTS: A total of 4054 images were taken during treatment. The difference in vector magnitude of the two methods is centered around zero (mean: 0.03 cm, SD: 0.16 cm) and Lin's Concordance Correlation Coefficient (CCC) is 0.99 (95% CI: 0.98, 1) overall. The Euclidean distance between the two methods was close to zero (median: 0.09 cm, IQR: 0.06, 0.14 cm). The difference in distance between any two markers was centered around zero (mean: 0.01 cm, SD: 0.12 cm) and Lin's CCC is 0.97 (95% CI: 0.96, 0.98) overall. CONCLUSION: The accuracy of the algorithm for detected markers within the 2D images is comparable to electromagnetic monitoring for fiducial identification when detected. IMR could provide an alternate solution for patients with contraindications of use of an electromagnetic monitoring system and a cost effective alternative to the acquisition of an additional system for patient monitoring, but does not provide data for pre-treatment set-up verification and real-time 3D positioning during treatment.
引用
- Cetnar A, Ayan AS, Graeper G, et al. Prospective dual-surrogate validation study of periodic imaging during treatment for accurately monitoring intrafraction motion of prostate cancer patients. Radiother Oncol. 2021. PMID: 33484751. doi:10.1016/j.radonc.2021.01.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。